Brain microRNA-mRNA regulatory networks and alcohol use disorders

大脑 microRNA-mRNA 调节网络和酒精使用障碍

基本信息

  • 批准号:
    9976401
  • 负责人:
  • 金额:
    $ 35.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-01 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Alcohol use disorders (AUDs) are characterized by compulsive and uncontrolled alcohol use, leading to social and occupational impairments. While genetic variation can result in an increased risk of AUDs, chronic alcohol consumption can independently lead to alcohol tolerance and dependence. However, it is unknown how chronic alcohol consumption alters gene expression and leads to neuroadaptations underlying AUDs. There is evidence that small noncoding microRNAs (miRNAs), which regulate target gene (or mRNA) expression at the posttranscriptional level, are abundant in the brain and play important roles in a variety of biological processes such as neuronal differentiation and synapse formation and plasticity. Additionally, each miRNA can regulate the expression of a number of different target mRNAs and each mRNA can be targeted by different miRNAs. Thus, brain miRNAs that regulate the expression of alcohol-responsive mRNAs may act upstream of alcohol- induced neuroadaptations. The objective of the proposed study is to identify dysregulated miRNAs and their target mRNAs in the brains of AUD subjects and generate AUD-associated miRNA-mRNA regulatory networks. The central hypothesis is that AUD-associated miRNAs interact with target mRNAs in reward-related brain regions, forming miRNA-mRNA regulatory networks that are critical for AUD development. This hypothesis will be tested by pursuing three specific aims: (1) identify differentially expressed miRNAs and mRNAs in at least eight reward-related brain regions (prefrontal cortex, nucleus accumbens, ventral tegmental area, hippocampus, amygdala, putamen, caudate, and cerebellum) of AUD subjects using next-generation sequencing (miRNA-Seq and mRNA-Seq); (2) generate AUD-associated miRNA-mRNA regulatory networks in reward-related brain regions using integrated bioinformatics analyses; and (3) refine AUD-associated miRNA- mRNA regulatory networks by validating the predicted miRNA-mRNA pairs using experimental approaches, such as high throughput 3' UTR reporter assays in cell lines and miRNA-mRNA interaction analyses in human embryonic stem cell (hESC)-derived GABAergic cortical neurons (as an in vitro cellular model). The proposed research is significant because it will identify and validate AUD-associated miRNA-mRNA regulatory networks in reward-related brain regions, thus improving our understanding of the epigenetic mechanisms of AUDs. The proposed research is innovative because advanced technologies (such as next-generation sequencing, state- of-the-art bioinformatics programs for miRNA-mRNA network construction, high-throughput 3' UTR reporter assay, and miRNA-mRNA interaction modeling in stem cell-derived neurons) will be used. Our long-term goal is to develop novel pharmacological treatment for AUDs by targeting specific miRNAs and their target genes.
项目摘要/摘要 酒精使用障碍(AUD)的特征是强迫性和不受控制的酒精使用,导致社交 和职业障碍。虽然遗传变异会导致频率增加,但慢性酒精 消费可以独立导致酒精耐受性和依赖性。但是,这是未知的 慢性酒精消耗会改变基因表达,并导致auds的神经适应。有 有证据表明,调节靶基因(或mRNA)表达的小型非编码microRNA(miRNA) 转录后级别在大脑中丰富,并且在各种生物过程中起重要作用 例如神经元分化和突触形成和可塑性。另外,每个miRNA都可以调节 许多不同靶mRNA和每个mRNA的表达可以由不同的miRNA靶向。 因此,调节酒精反应性mRNA表达的脑miRNA可能在酒精上游作用 - 诱导的神经照射。拟议研究的目的是确定miRNA及其失调 在AUD受试者的大脑中靶向mRNA,并产生与AUD相关的miRNA-MRNA调节 网络。中心假设是AUD相关的miRNA与奖励相关的目标mRNA相互作用 大脑区域,形成对AUD开发至关重要的miRNA-MRNA调节网络。这 假设将通过追求三个具体目标来检验:(1)确定差异表达的miRNA和 至少八个与奖励相关的大脑区域中的mRNA(前额叶皮层,伏隔核,腹侧段 使用下一代的AUD受试者区域,海马,杏仁核,putamen,尾状和小脑 测序(miRNA-SEQ和mRNA-SEQ); (2)在中产生与音频相关的miRNA-mRNA调节网络 使用综合生物信息学分析的奖励相关大脑区域; (3)完善与听到相关的miRNA- mRNA调节网络通过使用实验方法验证预测的miRNA-mRNA对, 例如在人类细胞系中的高吞吐量3'UTR报告基因测定和miRNA-MRNA相互作用分析 胚胎干细胞(HESC)衍生的GABA能皮质神经元(作为体外细胞模型)。提议 研究之所以重要,是因为它将识别和验证与AUD相关的miRNA-MRNA调节网络 在与奖励相关的大脑区域中,从而提高了我们对AUD的表观遗传机制的理解。这 拟议的研究具有创新性,因为先进的技术(例如下一代测序,国家 - miRNA-MRNA网络构建的艺术生物信息学计划,高通量3'UTR记者 将使用在干细胞衍生的神经元中的测定和miRNA-MRNA相互作用模型)。我们的长期目标 是通过靶向特定的miRNA及其靶基因来开发AUD的新型药理治疗。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of telomere length variation and Shelterin complex subunit gene expression changes in ethanol-exposed human embryonic stem cells.
  • DOI:
    10.1016/j.jpsychires.2020.11.027
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Moazzam M;Yim T;Kumaresan V;Henderson DC;Farrer LA;Zhang H
  • 通讯作者:
    Zhang H
Effect of Prenatal Opioid Exposure on the Human Placental Methylome.
  • DOI:
    10.3390/biomedicines10051150
  • 发表时间:
    2022-05-17
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
  • 通讯作者:
Internet addiction in college students and its relationship with cigarette smoking and alcohol use in Northeast China.
东北地区大学生网络成瘾及其与吸烟、饮酒的关系.
Atomoxetine in abstinent cocaine users: Sex differences.
戒除可卡因使用者中的托莫西汀:性别差异。
  • DOI:
    10.1016/j.dib.2017.08.011
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    1.2
  • 作者:
    DeVito,EliseE;Herman,AryehI;Konkus,NoahS;Zhang,Huiping;Sofuoglu,Mehmet
  • 通讯作者:
    Sofuoglu,Mehmet
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huiping Zhang其他文献

Huiping Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Huiping Zhang', 18)}}的其他基金

Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder
识别与酒精使用障碍相关的大脑表观转录组变化
  • 批准号:
    10580861
  • 财政年份:
    2022
  • 资助金额:
    $ 35.3万
  • 项目类别:
Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder
识别与酒精使用障碍相关的大脑表观转录组变化
  • 批准号:
    10343021
  • 财政年份:
    2022
  • 资助金额:
    $ 35.3万
  • 项目类别:
Salivary MicroRNAs as Biomarkers for Alcohol Dependence
唾液 MicroRNA 作为酒精依赖的生物标志物
  • 批准号:
    9059548
  • 财政年份:
    2015
  • 资助金额:
    $ 35.3万
  • 项目类别:
Salivary MicroRNAs as Biomarkers for Alcohol Dependence
唾液 MicroRNA 作为酒精依赖的生物标志物
  • 批准号:
    9521737
  • 财政年份:
    2015
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    7913072
  • 财政年份:
    2009
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    7813372
  • 财政年份:
    2009
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    8120382
  • 财政年份:
    2009
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    7925219
  • 财政年份:
    2009
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    7320738
  • 财政年份:
    2007
  • 资助金额:
    $ 35.3万
  • 项目类别:
Association and Function of Opioid Receptor Gene Variants to Substance Dependence
阿片受体基因变异与物质依赖性的关联和功能
  • 批准号:
    7496083
  • 财政年份:
    2007
  • 资助金额:
    $ 35.3万
  • 项目类别:

相似海外基金

The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
  • 批准号:
    10752274
  • 财政年份:
    2024
  • 资助金额:
    $ 35.3万
  • 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
  • 批准号:
    10817516
  • 财政年份:
    2023
  • 资助金额:
    $ 35.3万
  • 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
  • 批准号:
    10750357
  • 财政年份:
    2023
  • 资助金额:
    $ 35.3万
  • 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
  • 批准号:
    10668754
  • 财政年份:
    2023
  • 资助金额:
    $ 35.3万
  • 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 35.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了